Targeted Antimicrobial Agents as Potential Tools for Modulating the Gut Microbiome

被引:11
|
作者
Chou, Shuli [1 ]
Zhang, Shiqing [1 ]
Guo, Huating [1 ]
Chang, Yung-fu [2 ]
Zhao, Wenjing [1 ]
Mou, Xiangyu [1 ,3 ]
机构
[1] Shenzhen Campus Sun Yat Sen Univ, Ctr Infect & Immun Studies, Sch Med, Shenzhen, Peoples R China
[2] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY USA
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Dis, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
berberine; polyphenols; bacteriocins; antimicrobial peptides; phage therapy; targeted drug delivery system; pathobionts; microbiome editing; FUSOBACTERIUM-NUCLEATUM; ANTI-MRSA; BACTERIOCIN; PEPTIDE; ASSOCIATIONS; MECHANISM; DATABASE; PLANT; PH;
D O I
10.3389/fmicb.2022.879207
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The gut microbiome plays a pivotal role in maintaining the health of the hosts; however, there is accumulating evidence that certain bacteria in the host, termed pathobionts, play roles in the progression of diseases. Although antibiotics can be used to eradicate unwanted bacteria, the side effects of antibiotic treatment lead to a great need for more targeted antimicrobial agents as tools to modulate the microbiome more precisely. Herein, we reviewed narrow-spectrum antibiotics naturally made by plants and microorganisms, followed by more targeted antibiotic agents including synthetic peptides, phage, and targeted drug delivery systems, from the perspective of using them as potential tools for modulating the gut microbiome for favorable effects on the health of the host. Given the emerging discoveries on pathobionts and the increasing knowledge on targeted antimicrobial agents reviewed in this article, we anticipate targeted antimicrobial agents will emerge as a new generation of a drug to treat microbiome-involved diseases.
引用
收藏
页数:11
相关论文
共 50 条
  • [32] The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions
    Millares, Laura
    Monso, Eduard
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 1835 - 1845
  • [33] Proarrhythmic potential of antimicrobial agents
    Simko, J.
    Csilek, A.
    Karaszi, J.
    Lorincz, I.
    INFECTION, 2008, 36 (03) : 194 - 206
  • [34] VITAMIN A METABOLIC POTENTIAL OF HUMAN GUT MICROBIOME
    Rehman, Rahiya
    Bonakdar, Maryam
    Yadav, Aprajita S.
    Subedi, Shova
    Isoherranen, Nina
    Shapiro, Jason M.
    Vaishnava, Shipra
    GASTROENTEROLOGY, 2024, 166 (05) : S566 - S566
  • [35] Probiotics: Interaction with gut microbiome and antiobesity potential
    Arora, Tulika
    Singh, Satvinder
    Sharma, Raj Kumar
    NUTRITION, 2013, 29 (04) : 591 - 596
  • [36] Harvesting the biological potential of the human gut microbiome
    Willing, Benjamin P.
    Antunes, L. Caetano M.
    Keeney, Kristie M.
    Ferreira, Rosana B. R.
    Finlay, B. Brett
    BIOESSAYS, 2011, 33 (06) : 414 - 418
  • [37] Gut Microbiome as Potential Therapeutics in Multiple Sclerosis
    Wen Zhu
    Kiersten Dykstra
    Lili Zhang
    Zongqi Xia
    Current Treatment Options in Neurology, 2021, 23
  • [38] Proarrhythmic Potential of Antimicrobial Agents
    J. Simkó
    A. Csilek
    J. Karászi
    I. Lőrincz
    Infection, 2008, 36 : 194 - 206
  • [39] Biosynthetic potential of the gut microbiome in longevous populations
    Liu, Sheng
    Zhang, Zhao
    Wang, Xudong
    Ma, Yan
    Ruan, Hengfang
    Wu, Xing
    Li, Baoxia
    Mou, Xiangyu
    Chen, Tao
    Lu, Zhengqi
    Zhao, Wenjing
    GUT MICROBES, 2024, 16 (01)
  • [40] Skin exposure to sunlight: a factor modulating the human gut microbiome composition
    Conteville, Liliane Costa
    Vicente, Ana Carolina P.
    GUT MICROBES, 2020, 11 (05) : 1135 - 1138